INGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Inogen Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$6.55+0.30 (+4.80%)
Close on Oct 19, 2026
- Market cap
- $177.15M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.82 (−21.74%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Inogen Inc grew revenue 3.2% to $354.30M over the twelve months to Jun 30, 2026. Free cash flow was -$4.98M.
Revenue
$354.30M
+3.2% vs. a year earlier
Operating income
-$30.85M
TTM Q2 2026
Free cash flow
-$4.98M
TTM Q2 2026
EPS, diluted
-$0.90
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $177.15M
- P/E ratio
- –
- Price to sales
- 0.50
- Price to book
- 1.01
- Dividend yield
- –
- Free cash flow yield
- -2.81%
Fundamentals
- Revenue
- $354.30M
- Net income
- -$24.60M
- EPS, diluted
- -$0.90
- Free cash flow
- -$4.98M
- Book value per share
- $6.47
- Diluted shares
- 27M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$354.30M+3.2% YoY
Gross profit
$157.69M+1.5% YoY
Operating income
-$30.85M
Net income
-$24.60M
EPS, diluted
-$0.90
Free cash flow
-$4.98M
Reported periodTrailing twelve months